4.5 Article

Long-term outcome in patients with nodal-positive breast cancer treated with sentinel lymph node biopsy alone after neoadjuvant chemotherapy

Journal

BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -

Publisher

SPRINGER
DOI: 10.1007/s10549-023-07104-w

Keywords

Breast Cancer; Nodal metastasis; Neoadjuvant chemotherapy; Sentinel lymph node biopsy; Axillary lymph node dissection

Categories

Ask authors/readers for more resources

This study suggests that patients who had complete disappearance of lymph nodes following neoadjuvant chemotherapy can be safely treated with SLNB alone, and have better survival rates compared to those who underwent ALND.
PurposeSentinel lymph node biopsy (SLNB) has yet to be accepted as the standard staging procedure in node positive (cN1) breast cancer patients who had clinical complete response in the axilla (cN0) following neoadjuvant chemotherapy (NAC), due to the presumed high false negative rate associated with SLNB in such scenario. This study aimed to determine whether there is a significant difference in the axillary recurrence rate (ARR) and long-term survival in this group of patients, receiving SLNB alone versus axillary lymph node dissection (ALND).MethodsA retrospective cohort of cN1 patients who were rendered cN0 by NAC from January 2014 to December 2018 were identified from the Asan Medical Center database. Patients' characteristics and outcomes were collected and analyzed.Results902 cN1 patients treated with NAC and turned cN0 were identified. 477 (52.9%) patients achieved complete pathological response in the axilla (ypN0). At a median follow up of 65 months, ARR was 3.2% in the SLNB only group and 1.8% in the ALND group (p = 0.398). DFS and OS were significantly worse in patients with ALND as compared to patients with SLNB only (p = 0.011 and 0.047, respectively). We noted more patients in the ALND group had T3-4 tumor. In the subgroup analysis, we showed that in the T1-2 subgroup (n = 377), there was no statistically significant difference in DFS and OS (p = 0.242 and 0.671, respectively) between SLNB only and ALND group.ConclusionOur findings suggest that cN1 patients who were converted to ypN0 following NAC may be safely treated with SLNB only.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available